These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9505892)
1. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Bruno MJ; Haverkort EB; Tijssen GP; Tytgat GN; van Leeuwen DJ Gut; 1998 Jan; 42(1):92-6. PubMed ID: 9505892 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial. Woo SM; Joo J; Kim SY; Park SJ; Han SS; Kim TH; Koh YH; Chung SH; Kim YH; Moon H; Hong EK; Lee WJ Pancreatology; 2016; 16(6):1099-1105. PubMed ID: 27618657 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Halm U; Löser C; Löhr M; Katschinski M; Mössner J Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531 [TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study. Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290 [TBL] [Abstract][Full Text] [Related]
5. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine. Stead RJ; Skypala I; Hodson ME Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269 [TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603 [TBL] [Abstract][Full Text] [Related]
7. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Stead RJ; Skypala I; Hodson ME; Batten JC Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study. Petersen W; Heilmann C; Garne S Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493 [TBL] [Abstract][Full Text] [Related]
9. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Dutta SK; Rubin J; Harvey J Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746 [TBL] [Abstract][Full Text] [Related]
11. Two enteric coated microspheres in cystic fibrosis. Williams J; MacDonald A; Weller PH; Fields J; Pandov H Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of enzymatic replacement therapy measured by turbidimetry and the lipaemic index in exocrine pancreatic insufficient young, growing pigs, fed a high-fat diet. Donaldson J; Fed'kiv O; Pawłowska M; Kowalik S; Erlwanger KH; Weström B; Kruszewska D; Pierzynowski SG Adv Med Sci; 2009; 54(1):7-13. PubMed ID: 19648084 [TBL] [Abstract][Full Text] [Related]
13. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Vyas H; Matthew DJ; Milla PJ Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245 [TBL] [Abstract][Full Text] [Related]
14. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery]. Farkas G; Leindler L; Mihalovits G Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130 [TBL] [Abstract][Full Text] [Related]
15. Fate of oral enzymes in pancreatic insufficiency. Guarner L; Rodríguez R; Guarner F; Malagelada JR Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976 [TBL] [Abstract][Full Text] [Related]
16. A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic efficiency. Mas A; Noble PJ; Cripps PJ; Batchelor DJ; Graham P; German AJ BMC Vet Res; 2012 Jul; 8():127. PubMed ID: 22839732 [TBL] [Abstract][Full Text] [Related]
17. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin. Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133 [TBL] [Abstract][Full Text] [Related]
19. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long-term study. Carroccio A; Pardo F; Montalto G; Japichino L; Iacono G; Collura M; Notarbartolo A Digestion; 1988; 41(4):201-6. PubMed ID: 3243379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]